APA (7th ed.) Citation

S, S., SP, N., S, G., L, F., V, A., KC, D. B., . . . R, F. (2026). Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases. Oncology and therapy, 14(2), 827. https://doi.org/10.1007/s40487-026-00433-y

Chicago Style (17th ed.) Citation

S, Sidana, et al. "Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases." Oncology and Therapy 14, no. 2 (2026): 827. https://doi.org/10.1007/s40487-026-00433-y.

MLA (9th ed.) Citation

S, Sidana, et al. "Real-World Description of Non-ICANS Neurologic Events Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Ciltacabtagene Autoleucel Using Two Large US Databases." Oncology and Therapy, vol. 14, no. 2, 2026, p. 827, https://doi.org/10.1007/s40487-026-00433-y.